|
FXR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.079600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.593830E-02 |
| Normal-vs-Stage2 |
1.494180E-02 |
| Normal-vs-Stage3 |
1.083720E-03 |
| Normal-vs-Stage4 |
3.327600E-02 |
| Stage1-vs-Stage2 |
5.225200E-01 |
| Stage1-vs-Stage3 |
1.872400E-01 |
| Stage1-vs-Stage4 |
9.901600E-01 |
| Stage2-vs-Stage3 |
7.635400E-01 |
| Stage2-vs-Stage4 |
5.753200E-01 |
| Stage3-vs-Stage4 |
3.190000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.401100E-03 |
| Normal-vs-AfricanAmerican |
8.391800E-01 |
| Normal-vs-Asian |
3.293700E-02 |
| Caucasian-vs-AfricanAmerican |
1.855750E-02 |
| Caucasian-vs-Asian |
7.025800E-01 |
| AfricanAmerican-vs-Asian |
6.230400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.255700E-03 |
| Normal-vs-Female |
6.815700E-03 |
| Male-vs-Female |
6.367200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.853600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.539500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.902110E-03 |
| Normal-vs-Age(81-100Yrs) |
1.081170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.253000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.855450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.084400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.346200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.810600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.807400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.484400E-01 |
| Classical-VS-Follicular |
1.034120E-02 |
| Classical-VS-Other |
8.187200E-01 |
| Classical-VS-Normal |
4.009700E-02 |
| Tall-VS-Follicular |
4.373200E-01 |
| Tall-VS-Other |
8.177800E-01 |
| Tall-VS-Normal |
2.945800E-02 |
| Follicular-VS-Other |
5.358200E-01 |
| Follicular-VS-Normal |
7.980200E-04 |
| Other-VS-Normal |
3.163800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.586200E-04 |
| Normal-vs-N1 |
2.555400E-03 |
| N0-vs-N1 |
7.075400E-01 |
|
|
